|
| | PF-04971729 Basic information |
| Product Name: | PF-04971729 | | Synonyms: | PF-04971729/PF04971729;1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-beta-L-idopyranose;Ertugliflozin, >=98%;Ertugliflozin : PF 04971729-00;Leuco methylthioninium;(1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol;Ertugliflozin Base;(1S,2S,3S,4R,5S)-(2,3,4-TRIS-BENZYLOXY-5-(4-CHLORO-3-(4-ETHOXY-BENZYL)-PHENYL)-68-DIOXA-BICYCLO(3.2.1)OCT-1-YL)-METHANOL | | CAS: | 1210344-57-2 | | MF: | C22H25ClO7 | | MW: | 436.88 | | EINECS: | | | Product Categories: | API | | Mol File: | 1210344-57-2.mol |  |
| | PF-04971729 Chemical Properties |
| Melting point | 65 - 66oC | | Boiling point | 630.5±55.0 °C(Predicted) | | density | 1.455 | | storage temp. | Sealed in dry,Store in freezer, under -20°C | | solubility | DMSO (Slightly), Methanol (Slightly) | | pka | 12.95±0.70(Predicted) | | form | Solid | | color | White to Off-White |
| | PF-04971729 Usage And Synthesis |
| Uses | Ertugliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor used to treat type 2 diabetes. | | Definition | ChEBI: Ertugliflozin is a diarylmethane. |
| | PF-04971729 Preparation Products And Raw materials |
|
